Venous thromboembolism (VTE), including deep venous thrombosis and pulmonary embolism, is the most common cause of 30-day morbidity in oncology patients following surgery due to their hypercoagulable state. To combat this, VTE prophylaxis with anticoagulation extending beyond hospital discharge, termed extended duration chemoprophylaxis (EDCP), has been proposed, with the most recent guidelines recommending 28 post-operative days of EDCP. However, the literature has demonstrated poor compliance to these recommendations. We extended the duration of EDCP to 28 days post hospital discharge, effectively creating a standard discharge prescription for all surgical oncology patients. Our aim is to assess our EDCP protocol on patient compliance and VTE rate following major oncologic resection. We performed a retrospective, single institution, cohort study that involved chart review and telephone survey on patients who underwent major open abdominopelvic oncologic resection. A total of 130 patients were included; 60 received EDCP and 68 did not. VTE rate for the EDCP cohort was 0% and 7.4% for the non-EDCP cohort (p = 0.04). 85% of patients were fully compliant with EDCP. No bleeding related complications with EDCP were identified. Our data is consistent with prior literature in demonstrating a lower VTE rate with EDCP without an increase in bleeding related complications and we have demonstrated that it is possible to achieve a high rate of patient compliance with EDCP.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Srinivasaiah N, Arsalani-Zadeh R, Monson JR (2012) Thrombo-prophylaxis in colorectal surgery: a National Questionnaire Survey of the members of the Association of Coloproctology of Great Britain and Ireland. Colorectal Dis 14(7):e390–e393. https://doi.org/10.1111/j.1463-1318.2012.02974.x
Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, Benjaafar N (2015) Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol 13:204. https://doi.org/10.1186/s12957-015-0592-8
Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243(1):89–95. https://doi.org/10.1097/01.sla.0000193959.44677.48
Bottaro FJ, Elizondo MC, Doti C, Bruetman JE, Perez Moreno PD, Bullorsky EO, Ceresetto JM (2008) Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis. Thromb Haemost 99(6):1104–1111. https://doi.org/10.1160/TH07-12-0759
Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 Suppl):338S–400S. https://doi.org/10.1378/chest.126.3_suppl.338S
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A, American Society of Clinical Oncology Clinical P (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(17):2189–2204. https://doi.org/10.1200/JCO.2013.49.1118
NICE (2018) Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. https://www.nice.org.uk/guidance/NG89
Streiff MB (2019) Cancer-associated venous thromboembolic bisease. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/vte.pdf. Accessed 7 Jan 2019
Zipple M, Itenberg E (2018) Improving adherence to recommended venous thromboembolic prophylaxis in abdominal and pelvic oncologic surgery. Surgery 164(4):900–904. https://doi.org/10.1016/j.surg.2018.06.023
Geahchan N, Basile M, Tohmeh M, registry D (2016) Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry. Springerplus 5(1):1541. https://doi.org/10.1186/s40064-016-3057-9
Barnard GA (1945) A new test for 2 × 2 tables. Nature 156(3954):177–177. https://doi.org/10.1038/156177a0
Ludbrook J (2008) Analysis of 2 × 2 tables of frequencies: matching test to experimental design. Int J Epidemiol 37(6):1430–1435. https://doi.org/10.1093/ije/dyn162
Mehta C, Senchaudhuri P (2003) Conditional versus unconditional exact tests for comparing two binomials. Cytel Softw Corp 675:1–5
Ruff SM, Weber KT, Khader A, Conte C, Kadison A, Sullivan J, Wang J, Zaidi R, Deutsch GB (2019) Venous thromboembolism in patients with cancer undergoing surgical exploration. J Thromb Thrombolysis 47(2):316–323. https://doi.org/10.1007/s11239-018-1774-3
We would like to thank Karen Hagglund, MS, for her contributions with the statistical analysis of the data.
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ascension St. John Hospital institutional review board; 1340191-1) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the telephone survey.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kanitra, J., Holtrop, J., Jawad, A. et al. Extended duration chemoprophylaxis for venous thromboembolism following abdominopelvic oncologic surgery. J Thromb Thrombolysis 50, 190–194 (2020). https://doi.org/10.1007/s11239-019-02002-9
- Venous thromboembolism
- Extended duration chemoprophylaxis
- Low molecular weight heparin